Anti-CD19 antibodies with reduced immunogenicity

Details for Australian Patent Application No. 2006332155 (hide)

Owner Merck Patent GmbH

Inventors Super, Michael; Stein, Pascal Andre; Davis, Jonathan H.

Agent Davies Collison Cave

Pub. Number AU-A-2006332155

PCT Pub. Number WO2007/076950

Priority 60/755,609 30.12.05 US

Filing date 21 December 2006

Wipo publication date 12 July 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

21 August 2008 PCT application entered the National Phase

  PCT publication WO2007/076950 Priority application(s): WO2007/076950

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006332156-Coated textiles

2006332148-System and method for the renovation of process water